Scarica l'app Stockscreener
3.71
1.09%
0.04
Dopo l'orario di chiusura:
3.71
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.67
Aprire:
$3.67
Volume 24 ore:
765.27K
Relative Volume:
1.00
Capitalizzazione di mercato:
$711.20M
Reddito:
$12.99M
Utile/perdita netta:
$-74.39M
Rapporto P/E:
-8.4318
EPS:
-0.44
Flusso di cassa netto:
$-78.92M
1 W Prestazione:
+3.34%
1M Prestazione:
+12.42%
6M Prestazione:
+10.09%
1 anno Prestazione:
-3.13%
Intervallo 1D:
$3.65
$3.73
Intervallo di 1 settimana:
$3.49
$3.73
Portata 52W:
$2.705
$4.725
Arbutus Biopharma Corp Stock (ABUS) Company Profile
Nome
Arbutus Biopharma Corp
Settore
Industria
Telefono
604-419-3200
Indirizzo
701 VETERANS CIRCLE, WARMINSTER, PA
Confronta ABUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corp
|
3.71 | 703.53M | 12.99M | -74.39M | -78.92M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-02-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-25 | Iniziato | Jefferies | Hold |
| 2020-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-27 | Ripresa | JMP Securities | Mkt Outperform |
| 2020-07-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-05-19 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2020-03-06 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2020-02-20 | Iniziato | Robert W. Baird | Outperform |
| 2020-02-05 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-10-07 | Reiterato | B. Riley FBR | Buy |
| 2019-10-04 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-10-16 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-10-15 | Aggiornamento | Wedbush | Underperform → Neutral |
| 2018-10-12 | Reiterato | Chardan Capital Markets | Buy |
| 2018-07-06 | Downgrade | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-03-19 | Ripresa | Chardan Capital Markets | Buy |
| 2018-03-19 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-01-05 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-04-04 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2017-02-01 | Reiterato | Wedbush | Outperform |
| 2016-12-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2016-11-30 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
Mostra tutto
Arbutus Biopharma Corp Borsa (ABUS) Ultime notizie
Real time scanner hits for Arbutus Biopharma Corporation explainedJuly 2025 Closing Moves & High Return Stock Watch Alerts - Newser
Analyzing recovery setups for Arbutus Biopharma Corporation investorsPortfolio Performance Summary & High Accuracy Buy Signal Tips - Newser
How to build a custom watchlist for Arbutus Biopharma CorporationEarnings Growth Summary & AI Driven Stock Movement Reports - Newser
Technical signs of recovery in Arbutus Biopharma Corporation2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser
Chart based analysis of Arbutus Biopharma Corporation trendsJuly 2025 Reactions & Consistent Return Strategy Ideas - Newser
How to read the order book for Arbutus Biopharma CorporationWeekly Earnings Recap & Daily Risk Controlled Trade Plans - Newser
Developing predictive dashboards with Arbutus Biopharma Corporation dataCEO Change & Daily Stock Trend Reports - Newser
Arbutus Biopharma Corporation stock outlook for YEARMarket Rally & Weekly Stock Performance Updates - Newser
Can swing trading help recover from Arbutus Biopharma Corporation lossesWeekly Trade Recap & High Return Trade Guides - Newser
Custom watchlist performance reports with Arbutus Biopharma CorporationLayoff News & Smart Swing Trading Techniques - Newser
Applying sector rotation models to Arbutus Biopharma CorporationJuly 2025 Fed Impact & AI Based Buy and Sell Signals - Newser
Measuring Arbutus Biopharma Corporation’s beta against major indicesJuly 2025 Spike Watch & High Yield Stock Recommendations - Newser
Key metrics from Arbutus Biopharma Corporation’s quarterly data2025 Fundamental Recap & Low Risk Growth Stock Ideas - Newser
Real time pattern detection on Arbutus Biopharma Corporation stockEarnings Risk Report & Community Driven Trade Alerts - Newser
Deutsche Bank AG Cuts Stock Position in Arbutus Biopharma Corporation $ABUS - Defense World
Will Arbutus Biopharma Corporation outperform the marketJuly 2025 Opening Moves & Advanced Technical Signal Analysis - Newser
Published on: 2025-08-27 18:23:29 - Newser
Multi asset correlation models including Arbutus Biopharma Corporation2025 Sector Review & Weekly High Conviction Ideas - Newser
Analyzing net buyer seller activity in Arbutus Biopharma CorporationWeekly Risk Summary & Weekly Setup with High ROI Potential - Newser
Forecasting Arbutus Biopharma Corporation price range with options dataMarket Growth Report & Growth Oriented Trade Recommendations - Newser
Is Arbutus Biopharma Corporation stock entering bullish territory2025 Top Decliners & Smart Swing Trading Techniques - Newser
Will Arbutus Biopharma Corporation bounce back from current supportStop Loss & Precise Swing Trade Alerts - Newser
Arbutus Biopharma Corporation’s volatility index tracking explainedWeekly Market Report & Safe Entry Point Alerts - Newser
Sentiment analysis tools applied to Arbutus Biopharma CorporationJuly 2025 Volume & AI Driven Stock Reports - Newser
Real time social sentiment graph for Arbutus Biopharma CorporationJuly 2025 Retail & Free High Return Stock Watch Alerts - Newser
Arbutus Biopharma Corp Azioni (ABUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):